Vaccine

There are many things Vanderbilt community members can do to protect themselves, as well as their friends, colleagues and fellow community members, from various illnesses. Among them is getting the new bivalent COVID vaccine booster, which targets the omicron subvariants that currently make up 99 percent of new cases in the U.S. Read More

Christian Ketel and Carrie Plummer, both associate professors of nursing, were recognized by the American Association of Nurse Practitioners for their stewardship and successful outcomes of the Vanderbilt Mobile Vaccine Program. Since its start in March 2021, the mobile clinic has administered 15,000 COVID-19 vaccines to more than 6,500 people in Nashville and Bedford, Coffee, Rutherford, Williamson and Wilson counties. Read More

Assistant Professors of Nursing Christian Ketel and Carrie Plummer have received Vanderbilt’s 2022 Martin Luther King Jr. Award for developing and leading the Vanderbilt University School of Nursing/Vanderbilt University Medical Center Mobile Vaccine Program. Read More

As announced last month, COVID-19 vaccinations will be required for all members of the Vanderbilt University community for the 2021–22 academic year. The university is sharing additional guidance about this requirement.  Read More

Vanderbilt Occupational Health will host no-cost walk-up COVID-19 vaccine clinics starting in early June for university-employed faculty, staff and postdoctoral fellows. Vanderbilt recently announced that all university-employed faculty, staff and postdocs are required to be fully vaccinated against COVID-19 for the 2021–22 academic year. Read More

Following revised  CDC recommendations  indicating that fully vaccinated people  no longer need to wear masks or physically distance, Vanderbilt University today announced it is modifying many  COVID-19 protocols surrounding masking, gathering size, off-campus activities and campus visits. Additionally, the university will require all Vanderbilt University–employed faculty, staff and postdoctoral fellows to be fully vaccinated against COVID-19 for the 2021–22 academic school year.  The deadline for faculty, staff and postdocs to submit... Read More

After the FDA emergency authorization approval of the Pfizer vaccine for 12–15-year-olds, Monroe Carell Jr. Children’s Hospital at Vanderbilt has begun offering vaccine appointments for children and teenagers meeting the state criteria.    Read More

Behavioral science research from Jennifer Trueblood, associate professor of psychology, identifies the best way to convince people to get vaccinated against SARS-CoV-2. Read More

The isolation of human monoclonal antibodies against dangerous viruses including EEEV, Hendra and Nipah could offer new ways to treat and prevent these infections. Read More

Younger parents were much less likely than older parents to say they planned to vaccinate their children and themselves against COVID-19. Read More

Understanding immunity generated by smallpox vaccine may hold lessons for COVID-19 vaccine development. Read More

An experimental coronavirus vaccine stimulated robust immune responses against SARS-CoV-2, the virus that causes COVID-19, and raised no serious safety concerns in an early-stage clinical trial. Read More

Understanding how RSV is transmitted, which strains dominate and how new strains emerge around the globe will guide better vaccine and anti-viral drug design. Read More

Common sequences of antibodies against HIV may be key to developing a successful vaccine strategy for the virus. Read More

A new Vanderbilt study suggests it may be possible to develop antibody therapies or a universal vaccine effective against multiple Ebola virus family members. Read More

Newly discovered features in an RSV protein may be useful for rational structure-based vaccine design. Read More

The National Vaccine Program Office in the U.S. Department of Health and Human Services has selected William Schaffner, M.D., to receive its 2017 NVPO UpShot Award in Vaccine Communication. Read More

High dose flu vaccine boosts the immune response in older adults by increasing activation of certain immune cells. Read More

The compound MPLA is an attractive vaccine component, designed to elicit a robust immune response. Read More

High-dose influenza vaccine is 24 percent more effective than the standard-dose vaccine in protecting persons ages 65 and over against influenza illness and its complications. Read More